CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Apollo Medical Holdings, Inc. - AMEH CFD

    33.30
    0.36%
    0.13
    Low: 32.57
    High: 33.59
    Market Trading Hours* (UTC) Opens on Monday at 14:30

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.13
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Apollo Medical Holdings Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 33.18
    Open* 32.87
    1-Year Change* 12.53%
    Day's Range* 32.57 - 33.59
    52 wk Range 26.89-40.81
    Average Volume (10 days) 211.45K
    Average Volume (3 months) 3.90M
    Market Cap 1.55B
    P/E Ratio 33.63
    Shares Outstanding 47.14M
    Revenue 1.33B
    EPS 0.98
    Dividend (Yield %) N/A
    Beta 0.87
    Next Earnings Date Feb 21, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 33.30 0.85 2.62% 32.45 33.67 32.45
    Dec 7, 2023 33.18 0.73 2.25% 32.45 33.18 32.45
    Dec 6, 2023 33.41 -0.36 -1.07% 33.77 34.16 32.97
    Dec 5, 2023 33.55 -0.67 -1.96% 34.22 34.55 33.49
    Dec 4, 2023 34.78 1.31 3.91% 33.47 34.83 33.47
    Dec 1, 2023 34.75 1.97 6.01% 32.78 34.78 32.78
    Nov 30, 2023 33.18 0.07 0.21% 33.11 33.66 32.99
    Nov 29, 2023 33.42 0.96 2.96% 32.46 34.42 32.46
    Nov 28, 2023 33.64 0.13 0.39% 33.51 34.09 33.08
    Nov 27, 2023 33.89 0.03 0.09% 33.86 34.56 33.65
    Nov 24, 2023 34.18 2.17 6.78% 32.01 34.39 32.01
    Nov 22, 2023 33.36 0.60 1.83% 32.76 34.11 32.52
    Nov 21, 2023 32.66 -0.06 -0.18% 32.72 33.45 31.96
    Nov 20, 2023 33.96 -0.69 -1.99% 34.65 34.70 33.36
    Nov 17, 2023 35.07 1.10 3.24% 33.97 35.44 33.97
    Nov 16, 2023 34.84 1.13 3.35% 33.71 34.89 33.29
    Nov 15, 2023 34.23 1.71 5.26% 32.52 35.81 32.52
    Nov 14, 2023 34.07 2.53 8.02% 31.54 34.11 31.54
    Nov 13, 2023 31.28 1.33 4.44% 29.95 31.49 29.45
    Nov 10, 2023 30.09 -1.06 -3.40% 31.15 31.16 29.66

    Apollo Medical Holdings, Inc. Events

    Time (UTC) Country Event
    Wednesday, February 21, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Apollo Medical Holdings Inc Earnings Release
    Q4 2023 Apollo Medical Holdings Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1144.16 773.915 687.18 560.618 519.908
    Revenue 1144.16 773.915 687.18 560.618 519.908
    Cost of Revenue, Total 944.685 596.142 539.211 467.805 361.132
    Gross Profit 199.478 177.773 147.969 92.8132 158.776
    Total Operating Expense 1061.17 670.781 606.677 528.198 431.476
    Selling/General/Admin. Expenses, Total 77.67 62.077 49.116 40.119 47.2414
    Depreciation / Amortization 17.4 17.5 18.3 18.3 19.3
    Unusual Expense (Income) 21.271 -4.955 0 1.994 3.79887
    Operating Income 82.994 103.134 80.503 32.42 88.4322
    Interest Income (Expense), Net Non-Operating -0.322 -5.936 96.847 -9.61025 -7.42717
    Other, Net 3.944 -19.45 1.077 3.0302 1.62213
    Net Income Before Taxes 86.616 77.748 178.427 25.84 82.6271
    Net Income After Taxes 50.531 49.294 122.32 17.6733 60.2675
    Minority Interest -1.482 24.564 -84.454 -3.55677 -49.4325
    Net Income Before Extra. Items 49.049 73.858 37.866 14.1166 10.835
    Net Income 49.049 73.858 37.866 14.1166 10.835
    Income Available to Common Excl. Extra. Items 49.049 73.858 37.866 14.1166 10.835
    Income Available to Common Incl. Extra. Items 49.049 73.858 37.866 14.1166 10.835
    Diluted Net Income 49.049 73.858 37.866 14.1166 10.835
    Diluted Weighted Average Shares 45.6024 45.4031 37.4484 36.4033 37.9149
    Diluted EPS Excluding Extraordinary Items 1.07558 1.62672 1.01115 0.38778 0.28577
    Diluted Normalized EPS 1.3477 1.55752 1.01115 0.42525 0.35885
    Other Operating Expenses, Total 0.143 0.017 0.05 -0.0198 0.00318
    Total Extraordinary Items
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 348.209 337.244 294.208 317.001 269.697
    Revenue 348.209 337.244 294.208 317.001 269.697
    Cost of Revenue, Total 292.876 289.397 253.119 240.768 230.07
    Gross Profit 55.333 47.847 41.089 76.233 39.627
    Total Operating Expense 320.321 321.262 285.308 273.673 256.181
    Selling/General/Admin. Expenses, Total 24.056 21.18 24.446 21.388 19.894
    Depreciation / Amortization 3.3 3 3.1 3.4 3.5
    Other Operating Expenses, Total 0.948 1.293 0.963 1.354 0.851
    Operating Income 27.888 15.982 8.9 43.328 13.516
    Interest Income (Expense), Net Non-Operating 2.418 2.223 -0.061 -0.747 0.079
    Other, Net 1.185 1.204 1.616 -1.318 3.034
    Net Income Before Taxes 31.491 19.409 10.455 41.263 16.629
    Net Income After Taxes 17.482 12.488 0.471 27.396 11.277
    Minority Interest -4.312 0.644 -3.071 -1.41 0.673
    Net Income Before Extra. Items 13.17 13.132 -2.6 25.986 11.95
    Net Income 13.17 13.132 -2.6 25.986 11.95
    Income Available to Common Excl. Extra. Items 13.17 13.132 -2.6 25.986 11.95
    Income Available to Common Incl. Extra. Items 13.17 13.132 -2.6 25.986 11.95
    Diluted Net Income 13.17 13.132 -2.6 25.986 11.95
    Diluted Weighted Average Shares 46.7783 46.8112 45.4987 46.1525 46.023
    Diluted EPS Excluding Extraordinary Items 0.28154 0.28053 -0.05714 0.56305 0.25965
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.27135 0.36839 -0.00457 0.66034 0.28715
    Unusual Expense (Income) -0.859 6.392 3.68 6.763 1.866
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 428.125 398.782 338.577 329.068 172.863
    Cash and Short Term Investments 293.594 286.514 261.165 219.728 108.019
    Cash & Equivalents 288.027 233.097 193.47 103.189 106.892
    Total Receivables, Net 119.733 93.631 60.665 98.9503 56.456
    Accounts Receivable - Trade, Net 114.778 79.984 56.318 59.1399 56.456
    Prepaid Expenses 14.798 18.637 16.747 10.3151 8.38823
    Total Assets 966.213 852.363 817.486 728.713 512.999
    Property/Plant/Equipment, Total - Net 128.98 69.927 48.464 26.3776 12.7211
    Goodwill, Net 269.053 253.039 239.053 238.505 185.806
    Intangibles, Net 76.861 82.807 86.985 103.012 86.8759
    Other Long Term Assets, Total 6.056 4.628 19.415 2.42679 1.95143
    Total Current Liabilities 148.61 115.371 114.992 105.424 72.0197
    Payable/Accrued
    Notes Payable/Short Term Debt 0 0 0 0 0.04026
    Current Port. of LT Debt/Capital Leases 1.213 1.266 10.991 9.60174 0.10174
    Other Current Liabilities, Total 103.048 77.677 69.739 76.0021 58.3089
    Total Liabilities 423.652 397.813 486.662 537.164 332.453
    Total Long Term Debt 204.664 183.89 230.522 232.588 13.5173
    Long Term Debt 203.389 182.917 230.211 232.172 13
    Deferred Income Tax 14.217 9.127 10.959 18.2694 19.6159
    Minority Interest 15.986 61.45 114.324 169.511 226.115
    Other Liabilities, Total 40.175 27.975 15.865 11.3726 1.18503
    Total Equity 542.561 454.55 330.824 191.549 180.546
    Redeemable Preferred Stock
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.047 0.045 0.042 0.03591 0.03458
    Additional Paid-In Capital 360.097 310.876 261.011 159.608 162.723
    Retained Earnings (Accumulated Deficit) 182.417 143.629 69.771 31.9048 17.7882
    Total Liabilities & Shareholders’ Equity 966.213 852.363 817.486 728.713 512.999
    Total Common Shares Outstanding 46.5757 44.6309 42.2491 35.9081 34.578
    Total Preferred Shares Outstanding 1.66667 1.11111 1.11111 1.11111 1.66667
    Short Term Investments 5.567 53.417 67.695 116.539 1.1271
    Other Current Assets, Total 0 0 0.075 0
    Long Term Investments 41.195 42.611 80.367 29.3235 35.282
    Note Receivable - Long Term 15.943 0.569 4.625 0 17.5
    Accounts Payable 25.476 23.692 24.115 13.5919 8.57188
    Accrued Expenses 18.873 12.736 10.147 6.22825 4.99691
    Capital Lease Obligations 1.275 0.973 0.311 0.41552 0.51726
    Property/Plant/Equipment, Total - Gross 90.309 66.652 42.4008 26.722
    Accumulated Depreciation, Total -20.382 -18.188 -16.0232 -14.001
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 476.229 465.063 457.688 428.125 443.616
    Cash and Short Term Investments 276.962 297.71 278.727 293.594 217.297
    Cash & Equivalents 273.941 293.921 274.613 288.027 184.016
    Short Term Investments 3.021 3.789 4.114 5.567 33.281
    Total Receivables, Net 185.314 151.921 156.791 119.733 214.617
    Accounts Receivable - Trade, Net 182.84 149.747 153.88 114.778 160.594
    Prepaid Expenses 13.953 15.087 22.17 14.798 11.702
    Total Assets 1073.26 1027.18 992.628 966.213 943.406
    Property/Plant/Equipment, Total - Net 150.057 141.764 131.792 128.98 120.487
    Goodwill, Net 275.528 274.029 276.028 269.053 257.482
    Intangibles, Net 74.209 74.421 77.675 76.861 73.231
    Long Term Investments 47.324 48.727 44.004 41.195 39.85
    Note Receivable - Long Term 40.983 15.943 15.943 2.643
    Other Long Term Assets, Total 8.931 7.229 5.441 6.056 6.097
    Total Current Liabilities 202.957 185.794 164.954 148.61 156.191
    Accounts Payable 24.568 25.765 29.336 25.476 41.542
    Accrued Expenses 18.949 16.42 12.023 18.873 12.535
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 3.646 3.221 1.2 1.213 3.671
    Other Current Liabilities, Total 155.794 140.388 122.395 103.048 98.443
    Total Liabilities 479.547 461.164 432.584 423.652 432.968
    Total Long Term Debt 207.408 206.214 206.08 204.664 200.081
    Long Term Debt 206.213 205.136 204.944 203.389 199.15
    Capital Lease Obligations 1.195 1.078 1.136 1.275 0.931
    Deferred Income Tax 12.145 12.335 3.695 14.217 4.701
    Minority Interest 21.926 17.586 17.885 15.986 42.888
    Other Liabilities, Total 35.111 39.235 39.97 40.175 29.107
    Total Equity 593.714 566.012 560.044 542.561 510.438
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.047 0.047 0.047 0.047 0.045
    Additional Paid-In Capital 362.889 357.246 352.697 360.097 315.115
    Retained Earnings (Accumulated Deficit) 230.778 208.719 207.3 182.417 195.278
    Total Liabilities & Shareholders’ Equity 1073.26 1027.18 992.628 966.213 943.406
    Total Common Shares Outstanding 46.6074 46.5535 46.4884 46.5757 44.8845
    Total Preferred Shares Outstanding 1.66667 1.66667 1.66667 1.66667 1.66667
    Other Current Assets, Total 0.345 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 50.531 49.294 122.32 17.6733 60.2675
    Cash From Operating Activities 82.128 70.335 46.163 13.6734 25.496
    Cash From Operating Activities 17.543 17.517 18.35 18.7533 19.3032
    Deferred Taxes -7.681 -5.952 -6.62 -6.80092 -8.34524
    Non-Cash Items 31.318 29.597 -98.701 6.81924 17.3197
    Cash Taxes Paid 47.311 37.201 62.002 20.2 23.6427
    Cash Interest Paid 6.672 4.158 8.51 4.25754 0.46234
    Changes in Working Capital -9.583 -20.121 10.814 -22.7715 -63.0491
    Cash From Investing Activities -7.113 16.54 95.493 -180.631 -25.1828
    Capital Expenditures -22.94 -19.223 -1.164 -1.04167 -1.17006
    Other Investing Cash Flow Items, Total 15.827 35.763 96.657 -179.589 -24.0128
    Cash From Financing Activities -20.085 -47.748 -51.696 163.331 -11.1763
    Financing Cash Flow Items -4.61 -2.15 -1.037 -5.74394 0.0273
    Issuance (Retirement) of Stock, Net -0.617 43.456 10.265 -3.69098 -0.85097
    Issuance (Retirement) of Debt, Net -0.828 -57.965 -9.605 234.483 7.40613
    Net Change in Cash 54.93 39.127 89.96 -3.62654 -10.8631
    Total Cash Dividends Paid -14.03 -31.089 -51.319 -61.7174 -17.7588
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 14.307 50.531 50.06 22.664 12.073
    Cash From Operating Activities 7.72 82.128 -2.811 33.059 24.038
    Cash From Operating Activities 4.292 17.543 13.48 8.725 4.374
    Deferred Taxes 0.79 -7.681 -2.33 2.706 1.985
    Non-Cash Items 7.59 31.318 23.004 13.061 10.822
    Cash Taxes Paid 47.311 41.811 22.311 0
    Cash Interest Paid 2.991 6.672 4.386 2.231 0.845
    Changes in Working Capital -19.259 -9.583 -87.025 -14.097 -5.216
    Cash From Investing Activities -14.035 -7.113 -20.314 -12.228 -19.725
    Capital Expenditures -6.027 -22.94 -22.054 -18.845 -17.489
    Other Investing Cash Flow Items, Total -8.008 15.827 1.74 6.617 -2.236
    Cash From Financing Activities -7.099 -20.085 -25.956 -19.705 0.532
    Financing Cash Flow Items -9.539 -4.61 -4.271 -0.161 -0.162
    Total Cash Dividends Paid -0.12 -14.03 -12.676 -12.556 -1.178
    Issuance (Retirement) of Stock, Net 1.25 -0.617 -6.864 -7.742 1.343
    Issuance (Retirement) of Debt, Net 1.31 -0.828 -2.145 0.754 0.529
    Net Change in Cash -13.414 54.93 -49.081 1.126 4.845
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Allied Physicians of California, A Professional Medical Corporation Corporation 21.7914 10299259 107599 2023-04-25 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 12.7699 6035441 207106 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 10.0255 4738336 32257 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.2915 1555667 63134 2023-06-30 LOW
    Lam (Thomas S) Individual Investor 2.8227 1334086 -803507 2023-04-25 LOW
    Sim (Brandon) Individual Investor 2.5124 1187455 380053 2023-05-16 MED
    Young (Albert Waichow) Individual Investor 2.5067 1184749 1 2023-04-25 LOW
    Sim (Kenneth T) Individual Investor 2.159 1020418 -1111123 2023-04-25 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8235 861823 74520 2023-06-30 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.276 603060 108239 2023-06-30 LOW
    Steel Peak Wealth Management LLC Investment Advisor 1.036 489662 165227 2023-06-30 MED
    325 Capital LLC Investment Advisor 1.036 489653 132246 2023-06-30 LOW
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.8421 397982 29898 2023-06-30 LOW
    Atria Wealth Solutions, Inc. Investment Advisor 0.8101 382854 0 2023-06-30 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.659 311443 13179 2023-06-30 LOW
    Principal Global Investors (Equity) Investment Advisor 0.4927 232869 -10926 2023-06-30 LOW
    Mellon Investments Corporation Investment Advisor/Hedge Fund 0.4535 214339 -5813 2023-09-30 LOW
    Ziegler Capital Management, LLC Investment Advisor/Hedge Fund 0.4416 208721 17488 2023-09-30 LOW
    NorthCrest Asset Manangement LLC Investment Advisor 0.423 199931 0 2023-06-30 LOW
    RBC Global Asset Management (U.S.) Inc. Investment Advisor/Hedge Fund 0.4002 189125 14130 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Apollo Medical Holdings, Inc. Company profile

    About Apollo Medical Holdings Inc

    Apollo Medical Holdings, Inc. is a healthcare management company, which operates an integrated healthcare model. The Company through its subsidiary provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. It operates an integrated healthcare delivery platform that enables providers to participate in value-based care arrangements. To implement a patient-centered, physician-centric experience, the Company has other integrated and synergistic operations, including management service organizations (MSOs) that provide management and other services to its affiliated independent practice associations (IPAs), outpatient clinics, and hospitalists that coordinates the care of patients in hospitals.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Apollo Medical Holdings Inc revenues increased 13% to $773.9M. Net income increased 95% to $73.9M. Revenues reflect Medicare segment increase of 13% to $307.3M, Commercial segment increase of 27% to $138.3M. Net income benefited from Interest expense - Balancing value decrease of 43% to $5.4M (expense), Total Amort of Intangibles-excl Goodwill decrease of 4% to $15.4M (expense).

    Equity composition

    Common stock $0.001 Par, 11/10, 100M auth., 27,635,774 issd. Insider own 68.17%. Preferred stock $0.001 Par, 5Mauth. 04/15, 1-for-10 Reverse stock split.

    Industry: Healthcare Facilities & Services (NEC)

    1668 S Garfield Ave Fl 2nd
    ALHAMBRA
    CALIFORNIA 91801-5474
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Gold

    2,004.85 Price
    -1.180% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    BTC/USD

    44,039.40 Price
    -1.250% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    US100

    16,080.90 Price
    +0.500% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading